GlassScriptPhysician profile
Louise Vo
NPI 1316327570
$3,745.94
in general payments reported to CMS, 2019-2025
30 companies · $980 in 2025
The $980 reported for 2025 was more than what 86% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $231 · 2020: $29.44 · 2022: $587 · 2023: $975 · 2024: $944 · 2025: $980.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,899.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,898.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $615.95 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Glaxosmithkline, LLC. | $542.82 | 2019-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Boehringer Ingelheim Pharmaceuticals, INC. | $454.50 | 2022-2025 | Jardiance, Synjardy, Ofev |
| Novo Nordisk INC | $299.93 | 2019-2025 | Ozempic, Wegovy, Rybelsus |
| Pfizer INC. | $237.89 | 2023-2025 | |
| Astellas Pharma US INC | $221.14 | 2019-2025 | Veozah, Myrbetriq |
| Abbott Laboratories | $193.99 | 2022-2025 | Freestyle Libre 3 |
| Abbvie INC. | $155.18 | 2022-2025 | |
| Exact Sciences Corporation | $126.71 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Sumitomo Pharma America, INC. | $110.74 | 2025 | Gemtesa, Myfembree |
| Dynavax Technologies Corporation | $95.82 | 2022-2025 | Heplisav-B |
| Merck Sharp & Dohme LLC | $95.73 | 2019-2023 | Pneumovax 23, Vaxneuvance, Vaxelis |
| Amgen INC. | $90.78 | 2019-2024 | Repatha, Otezla, Evenity |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $73.13 | 2019-2023 | Xifaxan |
| Astrazeneca Pharmaceuticals LP | $59.47 | 2024-2025 | Airsupra |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dexcom, INC. | $55.72 | 2023-2025 | Dexcom G6 Transmitter |
| Inspire Medical Systems, INC. | $33.80 | 2024-2025 | Inspire |
| Sanofi-Aventis U.S. LLC | $30.63 | 2022-2023 | |
| Botanix Sb INC | $28.19 | 2025 | Sofdra |
| Ucb, INC. | $27.81 | 2024 | Bimzelx |
| Globus Medical, INC. | $25.11 | 2025 | Senza |
| Edwards Lifesciences Corporation | $23.77 | 2023 | |
| Sandoz INC. | $21.44 | 2024 | Hyrimoz |
| Biohaven Pharmaceutical Holding Company LTD. | $20.55 | 2022 | |
| Ultragenyx Pharmaceutical INC. | $20.49 | 2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $18.83 | 2022 | |
| Phathom Pharmaceuticals, INC. | $18.22 | 2023 | Voquezna |
| Novartis Pharmaceuticals Corporation | $16.54 | 2022 | |
| Gilead Sciences, INC. | $16.38 | 2020 | |
| Saluda Medical Americas, INC. | $14.68 | 2023 | Evoke Scs |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Louise Vo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.